Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Hepatitis C

  Free Subscription


Articles published in Transplant Proc

Retrieve available abstracts of 68 articles:
HTML format



Single Articles


    June 2021
  1. VAN HERCK J, Verbeek J, van Malenstein H, Laleman W, et al
    Liver-Related and Cardiovascular Outcome of Patients Transplanted for Nonalcoholic Fatty Liver Disease: A European Single-Center Study.
    Transplant Proc. 2021;53:1674-1681.
    PubMed     Abstract available


    December 2020
  2. LU YM, Yang WL, Chang CY, Ling SM, et al
    Clinical Experience of Patients With Hepatitis C Treated With Direct-Acting Antivirals After Heart Transplantation.
    Transplant Proc. 2020 Dec 17. pii: S0041-1345(20)32879.
    PubMed     Abstract available


    July 2020
  3. CHEVALLIER E, Buchler M, Caillard S, Bouvier N, et al
    Chronic Hepatitis C Virus Infection After Kidney Transplantation With or Without Direct-Acting Antivirals in a Real-Life Setting: A French Multicenter Experience.
    Transplant Proc. 2020 Jul 4. pii: S0041-1345(20)32581.
    PubMed     Abstract available


    June 2020
  4. GOHEL K, Borasadia P
    Sofosbuvir-Based HCV Treatment in Maintenance Hemodialysis Patients: A Single-Center Study.
    Transplant Proc. 2020 Jun 4. pii: S0041-1345(19)31894.
    PubMed     Abstract available


  5. NACIF LS, Aquino F, Tanigawa RY, Zanini LY, et al
    Histopathologic Evaluation of Acute on Chronic Liver Failure.
    Transplant Proc. 2020;52:1325-1328.
    PubMed     Abstract available


    May 2020
  6. CIECIURA T, Hryniewiecka E, Perkowska-Ptasinska A, Ciszek M, et al
    Shear Wave Elastography Performance in Noninvasive Assessment of Liver Cirrhosis in Liver Transplant Recipients With the Recurrence of Hepatitis C Infection.
    Transplant Proc. 2020 May 20. pii: S0041-1345(20)30094.
    PubMed     Abstract available


  7. EGUCHI S, Hidaka M, Natsuda K, Hara T, et al
    Simultaneous Deceased Donor Liver and Kidney Transplantation in a Human Immunodeficiency Virus/Hepatitis C Virus -Coinfected Patient With Hemophilia in Japan: A Case Report.
    Transplant Proc. 2020 May 14. pii: S0041-1345(20)32488.
    PubMed     Abstract available


    March 2020
  8. CIECIURA T, Hryniewiecka E, Foroncewicz B, Strzelczyk Z, et al
    Long-Term Follow-up of Liver Transplant Recipients Treated With Direct-Acting Antiviral Agents for Hepatitis C Recurrence After Transplantation.
    Transplant Proc. 2020 Mar 30. pii: S0041-1345(19)31656.
    PubMed     Abstract available


  9. CIECIURA T, Urbanowicz A, Foroncewicz B, Hryniewiecka E, et al
    Hepatocellular Carcinoma Is a Negative Predictor of Sustained Viral Response in Liver Transplant Recipients With Hepatitis C Treated With Direct-Acting Antivirals.
    Transplant Proc. 2020 Mar 30. pii: S0041-1345(19)31659.
    PubMed     Abstract available


  10. DEVRESSE A, Delire B, Lazarus JV, Kabamba B, et al
    Eliminating Hepatitis C Virus From a Prevalent Kidney Transplant Recipient Population: A Single-Center Study in Belgium in the Direct-Acting Antivirals Era.
    Transplant Proc. 2020 Mar 3. pii: S0041-1345(19)31337.
    PubMed     Abstract available


    February 2020
  11. MORENO-RAMIREZ M, Villanego F, Vigara LA, Cazorla JM, et al
    Direct-Acting Antiretroviral Therapy in Renal Transplant Recipients With Human Immunodeficiency Virus-Hepatitis C Virus Coinfection: Report of Our Experience and Literature Review.
    Transplant Proc. 2020 Feb 5. pii: S0041-1345(19)31131.
    PubMed     Abstract available


    January 2020
  12. EMORI CT, Uehara SNO, Amaral AC, Carvalho-Filho RJ, et al
    Observational Study Evaluating the Outcome of Cirrhotic Hepatitis C Patients Submitted to Renal Transplantation.
    Transplant Proc. 2020;52:89-96.
    PubMed     Abstract available


    December 2019
  13. BAYRAKTAR A, Akgul SU, Bakkaloglu H, Temurhan S, et al
    Can Direct-Acting Antiviral Treatment Change the Immunologic Risk Profile in Patients Infected with Hepatitis C Virus Who Are on the Cadaveric Waiting List?
    Transplant Proc. 2019 Dec 31. pii: S0041-1345(19)30884.
    PubMed     Abstract available


    November 2019
  14. PETRINI C, Trapani S, Riva L, Floridia G, et al
    Organ Transplantation From Nonstandard Risk Donors: Midway Between Rigid and Flexible Rules.
    Transplant Proc. 2019;51:2856-2859.
    PubMed     Abstract available


    October 2019
  15. VALENTE G, Miglioresi L, Sgueglia T, Rinaldi L, et al
    Toward Zero Hepatitis C Virus-Related Mortality as a Prerequisite for the Release of Resources in a Center for Follow-up of Liver Transplant.
    Transplant Proc. 2019 Oct 16. pii: S0041-1345(19)30585.
    PubMed     Abstract available


    August 2019
  16. SERIN A, Sahin T, Emek E, Arikan T, et al
    Role of Preoperative Viral Load and Presence of Hepatocellular Carcinoma in the Biliary Complications After Liver Transplantation Due to Hepatitis C Virus.
    Transplant Proc. 2019 Aug 9. pii: S0041-1345(19)30242.
    PubMed     Abstract available


  17. SERIN A, Sahin T, Arikan BT, Emek E, et al
    A Changing Etiologic Scenario in Liver Transplantation: A Single-Center Cohort Study From Turkey.
    Transplant Proc. 2019 Aug 8. pii: S0041-1345(18)31712.
    PubMed     Abstract available


    July 2019
  18. SIDDIQUI MB, Patel S, Bhati C, Reichman T, et al
    Range of Normal Serum Aminotransferase Levels in Liver Transplant Recipients.
    Transplant Proc. 2019;51:1895-1901.
    PubMed     Abstract available


    April 2019
  19. FAUST I, Weile J, Fujita B, Kandolf R, et al
    Heart Transplantation in Systemic Sclerosis: New Impulses for Conventional Scleroderma Transplantation Regimen and Scleroderma Diagnostic Monitoring: 2 Case Reports.
    Transplant Proc. 2019;51:865-870.
    PubMed     Abstract available


    November 2018
  20. HUANG TL, Chen TY, Tsang LC, Ou HY, et al
    Acoustic Radiation Force Impulse Elastography in Post-transplant Recurrent Hepatitis C in Living Donor Liver Transplantation.
    Transplant Proc. 2018;50:2695-2698.
    PubMed     Abstract available


  21. JUNG BH, Park JI, Lee SG
    Successful Treatment of Fibrosing Cholestatic Hepatitis With Daclatasvir and Asunaprevir After Liver Transplantation: A Case Report.
    Transplant Proc. 2018;50:2877-2881.
    PubMed     Abstract available


    September 2018
  22. WOJTOWICZ M, Wilkowski P, Hryniewiecka E, Cieciura T, et al
    Effect of Successful Treatment of Hepatitis C Virus Infection Recurrence With Direct-Acting Antiviral Agents on Physical Performance in Liver Transplant Recipients.
    Transplant Proc. 2018;50:2027-2030.
    PubMed     Abstract available


    July 2018
  23. PLISZCZYNSKI J, Jasztal K, Jozwik A, Kosieradzki M, et al
    Results of Renal Transplant From Deceased Anti-hepatitis C Virus Donors, Poland 1998-2012.
    Transplant Proc. 2018;50:1691-1696.
    PubMed     Abstract available


  24. WAZNA E, Pazik J, Perkowska-Ptasinska A, Durlik M, et al
    Does Histopathology of Implanted Kidney According to Banff 07 Help Predict Long-term Transplantation Outcome?
    Transplant Proc. 2018;50:1765-1768.
    PubMed     Abstract available


    June 2018
  25. GARCIA-PAJARES F, Tejedor-Tejada J, Torres-Yuste R, Almohalla-Alvarez C, et al
    Efficacy of Direct-acting Antivirals to Improve Clinical Condition, Fibrosis, and Liver Function in Liver Transplant Recipients Infected by Hepatitis C.
    Transplant Proc. 2018 Jun 30. pii: S0041-1345(18)30877.
    PubMed     Abstract available


  26. RAYA AM
    Influence of Donor Obesity on Long-Term Liver Transplantation Outcomes.
    Transplant Proc. 2018 Jun 30. pii: S0041-1345(18)30837.
    PubMed     Abstract available


  27. PESCHEL G, Moleda L, Baier L, Selgrad M, et al
    Safety of Direct-Acting Antiviral Therapy Regarding Renal Function in Post-Liver Transplant Patients Infected with Hepatitis C Virus and a 100% 12-Week Sustained Virologic Response-A Single-Center Study.
    Transplant Proc. 2018;50:1444-1450.
    PubMed     Abstract available


  28. BODRO M, Sanclemente G, Crespo G, Linares L, et al
    Severe Hepatitis C Recurrence as a Risk Factor for Opportunistic Infections in Liver Transplant Recipients.
    Transplant Proc. 2018;50:1437-1443.
    PubMed     Abstract available


  29. WAHAB MA, Shehta A, Elshoubary M, Yassen AM, et al
    Living-Donor Liver Transplantation in Hepatitis C Virus Era: A Report of 500 Consecutive Cases in a Single Center.
    Transplant Proc. 2018;50:1396-1406.
    PubMed     Abstract available


    April 2018
  30. IMAI H, Kamei H, Onishi Y, Ishizu Y, et al
    Diagnostic Usefulness of APRI and FIB-4 for the Prediction of Liver Fibrosis After Liver Transplantation in Patients Infected with Hepatitis C Virus.
    Transplant Proc. 2018 Apr 25. pii: S0041-1345(18)30211.
    PubMed     Abstract available


  31. ORUC A, Ersoy A
    Transplantation Opportunities of Hepatitis C Virus-Seropositive Patients on the Kidney Waiting List.
    Transplant Proc. 2018 Apr 18. pii: S0041-1345(18)30614.
    PubMed     Abstract available


  32. TAKEUCHI S, Takamura M, Yoshida T, Takahashi K, et al
    Ombitasvir-Paritaprevir-Ritonavir Therapy in a Kidney Transplant Recipient With Chronic Hepatitis C Virus Genotype 1 Infection: A Case Report on the Importance of Considering Drug-Drug Interactions and Monitoring Cyclosporine Levels.
    Transplant Proc. 2018;50:884-886.
    PubMed     Abstract available


  33. WEIGERT A, Querido S, Carvalho L, Lebre L, et al
    Hepatitis C Virus Eradication in Kidney Transplant Recipients: A Single-Center Experience in Portugal.
    Transplant Proc. 2018;50:743-745.
    PubMed     Abstract available


  34. MUCENIC M, Bandeira de Mello Brandao A, Marroni CA, Medeiros Fleck A Jr., et al
    Daclatasvir and Sofosbuvir With or Without Ribavirin in Liver Transplant Recipients: A Single-Center Real-World Study.
    Transplant Proc. 2018;50:769-771.
    PubMed     Abstract available


  35. MARTINO RB, Waisberg DR, Dias APM, Inoue VBS, et al
    Stratifying Mortality in a Model for End-Stage Liver Disease Waiting List: A Brazilian Single-Center Study.
    Transplant Proc. 2018;50:758-761.
    PubMed     Abstract available


    March 2018
  36. NOGUERAS LOPEZ F, Lopez Garrido A, Ortega Suazo EJ, Vadillo Calles F, et al
    Therapy With Direct-Acting Antiviral Agents for Hepatitis C in Liver Transplant Recipients.
    Transplant Proc. 2018;50:631-633.
    PubMed     Abstract available


  37. CAICEDO LA, Delgado A, Garcia VH, Aristizabal AM, et al
    Liver Transplantation in Hepatitis C-Infected Patients: Experience From a South American Transplant Center.
    Transplant Proc. 2018;50:493-498.
    PubMed     Abstract available


    January 2018
  38. MIUMA S, Miyaaki H, Miyazoe Y, Suehiro T, et al
    Development of Duodenal Ulcers due to the Discontinuation of Proton Pump Inhibitors After the Induction of Sofosbuvir Plus Ledipasvir Therapy: A Report of Two Cases.
    Transplant Proc. 2018;50:222-225.
    PubMed     Abstract available


    December 2017
  39. MOTOMURA T, Yoshizumi T, Ohira M, Mano Y, et al
    Successful Recombinant Thrombomodulin Treatment for Thrombotic Microangiopathy After Liver Transplantation: A Case Report.
    Transplant Proc. 2017;49:2409-2410.
    PubMed     Abstract available


    November 2017
  40. TOWNSEND SA, Monga MA, Nightingale P, Mutimer D, et al
    Hepatitis C Virus Recurrence Occurs Earlier in Patients Receiving Donation After Circulatory Death Liver Transplant Grafts Compared With Those Receiving Donation After Brainstem Death Grafts.
    Transplant Proc. 2017;49:2129-2134.
    PubMed     Abstract available


  41. ROULLET S, Defaye M, Quinart A, Adam JP, et al
    Liver Transplantation With Old Grafts: A Ten-Year Experience.
    Transplant Proc. 2017;49:2135-2143.
    PubMed     Abstract available


    October 2017
  42. FREY A, Ecker EM, Piras-Straub K, Walker A, et al
    Effects of the Mammalian Target of Rapamycin Inhibitor Everolimus on Hepatitis C Virus Replication In Vitro and In Vivo.
    Transplant Proc. 2017;49:1947-1955.
    PubMed     Abstract available


  43. LIAO HT, Tan P, Huang JW, Yuan KF, et al
    Ledipasvir + Sofosbuvir for Liver Transplant Recipients With Recurrent Hepatitis C: A Systematic Review and Meta-analysis.
    Transplant Proc. 2017;49:1855-1863.
    PubMed     Abstract available


    September 2017
  44. SHAFII AE, Harris DD 2nd, Baz M
    Clearance of Hepatitis C Virus Prior to Lung Transplantation: A Case Report.
    Transplant Proc. 2017;49:1682-1684.
    PubMed     Abstract available


  45. NAKANO R, Ohira M, Ishiyama K, Ide K, et al
    Acute Graft Rejection and Formation of De Novo Donor-Specific Antibodies Triggered by Low Cyclosporine Levels and Interferon Therapy for Recurrent Hepatitis C Infection After Liver Transplantation: A Case Report.
    Transplant Proc. 2017;49:1634-1638.
    PubMed     Abstract available


    July 2017
  46. TRONINA O, Slubowska K, Mikolajczyk-Korniak N, Komuda-Leszek E, et al
    Fibrosing Cholestatic Hepatitis C After Liver Transplantation: Therapeutic Options Before and After Introduction of Direct-Acting Antivirals: Our Experience and Literature Review.
    Transplant Proc. 2017;49:1409-1418.
    PubMed     Abstract available


    June 2017
  47. OHIRA M, Nishida S, Tryphonopoulos P, Ruiz P, et al
    Impact of Steroids on Natural Killer Cells Against Cytotoxicity and Hepatitis C Virus Replication.
    Transplant Proc. 2017;49:1160-1164.
    PubMed     Abstract available


  48. KOSHINO K, Ushigome H, Masuda K, Matsuyama T, et al
    Effective Treatment With Daclatasvir and Asunaprevir in Kidney Transplant Patients Infected With Hepatitis C Virus: A Report of Two Cases.
    Transplant Proc. 2017;49:1053-1055.
    PubMed     Abstract available


    May 2017
  49. PIAI G, Miglioresi L, Valente G
    Eradication of Hepatitis C After Liver Transplantion: Consequences for the Organization of the Transplant Patient's Follow-up.
    Transplant Proc. 2017;49:671-673.
    PubMed     Abstract available


  50. TRAPANI S, Rizzato L, Masiero L, Ricci A, et al
    Hepatitis C Virus Positive Patients on the Waiting List for Liver Transplantation: Turnover and Characteristics of the Population on the Eve of the Therapeutic Revolution With Direct-Acting Antivirals.
    Transplant Proc. 2017;49:658-666.
    PubMed     Abstract available


    January 2017
  51. MELLO F, Girao C, Castro CC, Fiuza S, et al
    De Mello's Single Incision for Combined Liver-kidney Transplantation, Keeping the Kidney Retroperitoneal: A Case Report.
    Transplant Proc. 2017;49:169-171.
    PubMed     Abstract available


    November 2016
  52. DENG G, Ma J, Shen S, Li Q, et al
    Sofosbuvir Monotherapy for Asymptomatic and Noncirrhotic Hepatitis C Infection in a Renal Retransplantation Recipient: A Case Report.
    Transplant Proc. 2016;48:3120-3122.
    PubMed     Abstract available


  53. SANCHEZ ANTOLIN G, Testillano M, Pascasio JM, Narvaez Rodriguez I, et al
    Efficacy and Safety of Therapy With Simeprevir and Sofosbuvir in Liver Transplant Recipients Infected by Hepatitis C Virus Genotype 4: Cohort Spanish Society of Liver Transplantation Cohort.
    Transplant Proc. 2016;48:3013-3016.
    PubMed     Abstract available


  54. BERGE E, Oton E, Reina Z, Diaz L, et al
    Predictors of Poor Prognosis in Recurrent Hepatitis C After Liver Transplantation.
    Transplant Proc. 2016;48:2997-2999.
    PubMed     Abstract available


  55. GENTIL MA, Gonzalez-Corvillo C, Perello M, Zarraga S, et al
    Hepatitis C Treatment With Direct-Acting Antivirals in Kidney Transplant: Preliminary Results From a Multicenter Study.
    Transplant Proc. 2016;48:2944-2946.
    PubMed     Abstract available


  56. SUAREZ BENJUMEA A, Gonzalez-Corvillo C, Sousa JM, Bernal Blanco G, et al
    Hepatitis C Virus in Kidney Transplant Recipients: A Problem on the Path to Eradication.
    Transplant Proc. 2016;48:2938-2940.
    PubMed     Abstract available


  57. GARCIA BERNARDO CM, Arguelles Garcia B, Redondo Buil P, Miyar de Leon A, et al
    Collateral Development in Thrombosis of the Hepatic Artery After Transplantation.
    Transplant Proc. 2016;48:3006-3009.
    PubMed     Abstract available


  58. SAFWAN M, Nagai S, Abouljoud MS
    Portal Vein Inflow From Enlarged Coronary Vein in Liver Transplantation: Surgical Approach and Technical Tips: A Case Report.
    Transplant Proc. 2016;48:3070-3072.
    PubMed     Abstract available


  59. CEPEDA-FRANCO C, Bernal-Bellido C, Barrera-Pulido L, Alamo-Martinez JM, et al
    Survival Outcomes in Liver Transplantation With Elderly Donors: Analysis of Andalusian Transplant Register.
    Transplant Proc. 2016;48:2983-2986.
    PubMed     Abstract available


    October 2016
  60. ALDEMIR E, Coskunol H, Kilic M, Sert I, et al
    Treatment of Opioid Dependence With Buprenorphine/Naloxone After Liver Transplantation: Report of Two Cases.
    Transplant Proc. 2016;48:2769-2772.
    PubMed     Abstract available


    September 2016
  61. BENITEZ-GUTIERREZ L, de Mendoza C, Banos I, Duca A, et al
    Drug-Induced Lung Injury in a Liver Transplant Patient Treated With Sofosbuvir.
    Transplant Proc. 2016;48:2515-2518.
    PubMed     Abstract available


    June 2016
  62. CZERWINSKI J, Lewandowska D, Malkowski P, Danielewicz R, et al
    Liver Transplant Registry in Poland: Web-Netted Quality Tool in Liver Transplantation From Deceased and Living Donors.
    Transplant Proc. 2016;48:1347-9.
    PubMed     Abstract available


  63. CZERWINSKI J, Lewandowska D, Malkowski P, Danielewicz R, et al
    Liver Donation and Transplantation in Poland: Numbers, Indicators, and Trends.
    Transplant Proc. 2016;48:1341-6.
    PubMed     Abstract available


    May 2016
  64. ASAVAKARN S, Sirivatanauksorn Y, Promraj R, Ruenrom A, et al
    Systematic Pharmaceutical Educational Approach to Enhance Drug Adherence in Liver Transplant Recipients.
    Transplant Proc. 2016;48:1202-7.
    PubMed     Abstract available


  65. KANG GW, Lee IH, Ahn KS, Kim JD, et al
    One-Year Follow-up of the Changes in Renal Function After Liver Transplantation in Patients Without Chronic Kidney Disease.
    Transplant Proc. 2016;48:1190-3.
    PubMed     Abstract available


    March 2016
  66. MORABITO V, Grossi P, Lombardini L, Ricci A, et al
    Solid Organ Transplantation in HIV+ Recipients: Italian Experience.
    Transplant Proc. 2016;48:424-30.
    PubMed     Abstract available


  67. FERLA F, Mariani A, di Sandro S, Buscemi V, et al
    Do Older Liver Grafts Have Worse Survival? The Niguarda Experience.
    Transplant Proc. 2016;48:362-5.
    PubMed     Abstract available


    January 2016
  68. LAM PH, Obirieze AC, Ortega G, Nwokeabia I, et al
    Characterization of Hepatitis B and C Among Liver Transplant Recipients With Hepatocellular Carcinoma: An Analysis of the Nationwide Inpatient Sample Database.
    Transplant Proc. 2016;48:123-7.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Hepatitis C is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: